Boardroom Alpha
Boardroom Alpha
BKNG · Current Report (Form 8-K) · Filed June 2, 2026

Booking Holdings Inc — Current Report (Form 8-K)

Form
8-K
Filed
June 2, 2026
Period
Jun 2, 2026
Ticker
BKNG
Accession
0001075531-26-000031
Boardroom Alpha · Filing insights

Stockholders elected directors; approved executive compensation, annual audit, and officer exculpation amendment; two governance proposals failed.

About Booking Holdings Inc
Market cap
$129.6B
1Y TSR
−25.3%
3Y TSR
+16.3%
Board grade
B
Sector
Industrials
CEO
Glenn D Fogel
Last annual meeting: Jun 2, 2026 · View full Booking Holdings Inc profile →
bkng-20260602

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported) June 2, 2026
 
Booking Holdings Inc.
(Exact name of registrant as specified in its charter)
 
Delaware1-3669106-1528493
(State or other Jurisdiction of
Incorporation)
(Commission File Number)(IRS Employer Identification No.)
 
800 Connecticut AvenueNorwalkConnecticut06854
(Address of principal executive offices)(zip code)
 
Registrant's telephone number, including area code: (203) 299-8000

N/A 
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
    Soliciting material pursuant to Rule 14a-12  under the Exchange Act (17 CFR 240.14a-12)
 
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))




Securities Registered Pursuant to Section 12(b) of the Act:
Title of Each Class: Trading SymbolName of Each Exchange on which Registered:
Common Stock par value $0.008 per share BKNGThe NASDAQ Global Select Market
4.000% Senior Notes Due 2026BKNG 26The NASDAQ Stock Market LLC
1.800% Senior Notes Due 2027BKNG 27The NASDAQ Stock Market LLC
0.500% Senior Notes Due 2028BKNG 28The NASDAQ Stock Market LLC
3.625% Senior Notes Due 2028BKNG 28AThe NASDAQ Stock Market LLC
4.250% Senior Notes Due 2029BKNG 29The NASDAQ Stock Market LLC
3.500% Senior Notes Due 2029BKNG 29AThe NASDAQ Stock Market LLC
3.000% Senior Notes Due 2030BKNG 30The NASDAQ Stock Market LLC
3.500% Senior Notes Due 2030BKNG 30AThe NASDAQ Stock Market LLC
4.500% Senior Notes Due 2031BKNG 31The NASDAQ Stock Market LLC
3.125% Senior Notes Due 2031BKNG 31AThe NASDAQ Stock Market LLC
3.625% Senior Notes Due 2032BKNG 32The NASDAQ Stock Market LLC
3.250% Senior Notes Due 2032BKNG 32AThe NASDAQ Stock Market LLC
4.125% Senior Notes Due 2033BKNG 33The NASDAQ Stock Market LLC
4.750% Senior Notes Due 2034BKNG 34The NASDAQ Stock Market LLC
4.000% Senior Notes Due 2034BKNG 34AThe NASDAQ Stock Market LLC
3.625% Senior Notes Due 2035BKNG 35The NASDAQ Stock Market LLC
3.750% Senior Notes Due 2036BKNG 36The NASDAQ Stock Market LLC
3.750% Senior Notes Due 2037BKNG 37The NASDAQ Stock Market LLC
4.125% Senior Notes Due 2038BKNG 38The NASDAQ Stock Market LLC
4.500% Senior Notes Due 2039BKNG 39The NASDAQ Stock Market LLC
4.000% Senior Notes Due 2044BKNG 44The NASDAQ Stock Market LLC
3.875% Senior Notes Due 2045BKNG 45The NASDAQ Stock Market LLC
4.500% Senior Notes Due 2046BKNG 46The NASDAQ Stock Market LLC
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 5.07.     Submission of Matters to a Vote of Security Holders.

The 2026 Annual Meeting of Stockholders of the Company was held virtually on June 2, 2026 at www.virtualshareholdermeeting.com/BKNG2026. Stockholders voted on the proposals as described below:

1. The following individuals were elected to the Company’s Board of Directors to serve until the next annual meeting of stockholders and until their successors are elected and qualified.


FOR

AGAINST

ABSTAIN

BROKER
NON-VOTE
Glenn D. Fogel
626,172,624

3,336,143

461,733

39,596,274
Mirian Graddick-Weir
617,626,448

11,873,023

471,029

39,596,274
Kelly Grier
624,491,573

5,001,928

476,999

39,596,274
Robert J. Mylod, Jr.
618,987,796

10,483,969

498,735

39,596,274
Charles H. Noski
568,161,578

60,586,704

1,222,218

39,596,274
Larry Quinlan
601,714,149

27,776,690

479,661

39,596,274
Nicholas J. Read
626,339,985

3,148,650

481,865

39,596,274
Thomas E. Rothman
612,655,856

16,837,680

476,964

39,596,274
Kurt Sievers
626,268,964

3,223,664

477,872

39,596,274
Sumit Singh
624,816,642

4,676,082

477,776

39,596,274
Vanessa A. Wittman
615,332,600

12,632,041

2,005,859

39,596,274

2. An advisory vote to approve 2025 executive compensation was approved.

FOR

AGAINST

ABSTAIN

BROKER
NON-VOTE
567,003,024

61,561,892

1,405,584

39,596,274

3. A proposal to ratify the selection of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for fiscal year 2026 was approved.


FOR

AGAINST

ABSTAIN
610,788,541

57,141,803

1,636,430

4. A proposal to approve an amendment of the Company’s certificate of incorporation to provide for the exculpation of officers was approved.

FOR

AGAINST

ABSTAIN

BROKER
NON-VOTE
549,857,878

79,183,201

929,421

39,596,274





5. A stockholder proposal requesting a non-binding vote on a proposal to avoid brand damage due to corporate political spending was not approved.

FOR

AGAINST

ABSTAIN

BROKER
NON-VOTE
220,677,778

406,392,027

2,900,695

39,596,274


6. A stockholder proposal requesting a non-binding vote on a resolution regarding business operations in illegal settlements was not approved.

FOR

AGAINST

ABSTAIN

BROKER
NON-VOTE
64,039,145

558,090,578

7,840,777

39,596,274



Item 9.01.     Financial Statements and Exhibits.
 
(d)    Exhibits
Exhibit
Number
Description
104Cover Page Interactive Data File - the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.






SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 BOOKING HOLDINGS INC.
  
   
 By:/s/ Peter J. Millones
  Name:Peter J. Millones
  Title:Executive Vice President and General Counsel
 
 
Date:  June 2, 2026


From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Booking Holdings Inc (BKNG)

Reference

Frequently asked questions

When did Booking Holdings Inc file this 8-K?
Booking Holdings Inc (BKNG) filed this Current Report (Form 8-K) with the SEC on June 2, 2026. The accession number assigned by EDGAR is 0001075531-26-000031.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Stockholders elected directors; approved executive compensation, annual audit, and officer exculpation amendment; two governance proposals failed. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Booking Holdings Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Booking Holdings Inc has filed under CIK 1075531, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer